12:00 AM
 | 
Feb 13, 2012
 |  BC Week In Review  |  Company News  |  Deals

Tris Pharma, Vernalis deal

Tris granted Vernalis exclusive, North American rights to commercialize six reformulated cough and cold products using Tris' extended release formulation technology. Tris,...

Read the full 89 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >